These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 1468194)

  • 1. [Intravenous immunoglobulins. General features and the main clinical applications].
    Agostini G; Antonelli A
    Clin Ter; 1992 Sep; 141(9 Pt 2):17-32. PubMed ID: 1468194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravenous immunoglobulins as therapeutic agents.
    Stiehm ER; Ashida E; Kim KS; Winston DJ; Haas A; Gale RP
    Ann Intern Med; 1987 Sep; 107(3):367-82. PubMed ID: 3304051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Current therapeutic use of gamma globulin preparations].
    Litzman J
    Cas Lek Cesk; 1991 Nov; 130(18-19):556-60. PubMed ID: 1764720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [High dose intravenous immunoglobulins in therapeutic arsenal in autoimmune and systemic diseases].
    Klein M; Kaminsky P; Duc M
    Therapie; 1993; 48(2):97-103. PubMed ID: 8351694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of intravenous immunoglobulin G in autoimmune hematologic disorders.
    Blanchette VS; Kirby MA; Turner C
    Semin Hematol; 1992 Jul; 29(3 Suppl 2):72-82. PubMed ID: 1509297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Applications of intravenous immunoglobulin.
    Yap PL
    Malays J Pathol; 1990 Jun; 12(1):1-10. PubMed ID: 2090883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Current developments in the use of intravenous immunoglobulins].
    Bardare M; Dellepiane RM
    Minerva Pediatr; 1991 Nov; 43(11):665-74. PubMed ID: 1791793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prevention of infections in primary and secondary antibody deficiency].
    Mikołuć B; Pietrucha B; Motkowski R; Wolska-Kuśnierz B; Heropolitańska-Pliszka E; Bernatowska E
    Przegl Epidemiol; 2009; 63(1):55-60. PubMed ID: 19522227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Use of intravenous immunoglobulin in treatment of neoplasms and hematologic disorders in children].
    Wróbel G; Chybicka A; Kazanowska B
    Postepy Hig Med Dosw; 2002; 56 Suppl():59-68. PubMed ID: 12661416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous immunoglobulin and autoimmune disease.
    El-Shanawany T; Jolles S
    Ann N Y Acad Sci; 2007 Sep; 1110():507-15. PubMed ID: 17911466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous immunoglobulins in the therapy of autoimmune and systemic inflammatory disorders.
    Mobini N; Sarela A; Ahmed AR
    Ann Allergy Asthma Immunol; 1995 Feb; 74(2):119-28; quiz 128-33. PubMed ID: 7697470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of cost of immune globulin intravenous therapy to conventional immunosuppressive therapy in treating patients with autoimmune mucocutaneous blistering diseases.
    Daoud YJ; Amin KG
    Int Immunopharmacol; 2006 Apr; 6(4):600-6. PubMed ID: 16504922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [New indications for gamma globulins].
    Fontán G; García MC; Pascual-Salcedo D; López Trascasa M; Alvarez Doforno R; Ferreira A
    An Esp Pediatr; 1992 Jun; 36 Suppl 48():135-8. PubMed ID: 1379010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Intravenous gamma globulins (i.v.IG) in the treatment and prevention of virus infections].
    Bucholc B
    Przegl Epidemiol; 1992; 46(3):231-6. PubMed ID: 1338350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Immunoglobulins in Hematology. Immunologic thrombopenic purpura].
    Zini JM; Tobelem G
    Ann Med Interne (Paris); 1993; 144(8):514-7. PubMed ID: 8179239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immunomodulatory effects of intravenous immunoglobulins].
    Kazatchkine M; Mouthon L; Kaveri SV
    Ann Med Interne (Paris); 2000 May; 151 Suppl 1():1S13-8. PubMed ID: 10896983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravenous immunoglobulin: an emerging treatment for immune-mediated skin diseases.
    Rütter A; Luger TA
    Curr Opin Investig Drugs; 2002 May; 3(5):713-9. PubMed ID: 12090544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-dose intravenous immunoglobulins: an approach to treat severe immune-mediated and autoimmune diseases of the skin.
    Rütter A; Luger TA
    J Am Acad Dermatol; 2001 Jun; 44(6):1010-24. PubMed ID: 11369915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous immunoglobulin: new clinical applications.
    Steele RW; Burks AW; Williams LW
    Ann Allergy; 1988 Feb; 60(2):89-94. PubMed ID: 2829663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of autoimmune disease: synergy between plasma exchange and intravenous immunoglobulins.
    Nydegger UE; Sturzenegger T
    Ther Apher; 2001 Jun; 5(3):186-92. PubMed ID: 11467755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.